Francisco Javier Blanco García, (1963, Honorary son of Cee, A Coruña) is a Spanish medical professional who has established a notable career in the field of rheumatology. [1] He holds the position of full professor in the Department of Physiotherapy, Medicine, and Biomedical Sciences at the Universidad de A Coruña. [2] Additionally, he serves as the Head of the Clinical and Translational Rheumatology Section at the A Coruña University Hospital and is the Coordinator of the Rheumatology-Health Research Group ( GIR) at INIBIC and CICA-UDC. [3] Francisco J Blanco is also a Corresponding Academic of the Royal National Academy of Medicine of Spain, [4] the Royal National Academy of Pharmacy of Spain, [5] and the Royal Academy of Medicine and Surgery of Galicia. [6] Recently, he was appointed Director of the Cathedra San Rafael Foundation-UDC. [7]
Research
Prof. Francisco Javier Blanco García's research is mainly focused on rheumatology, particularly in understanding osteoarthritis. [8] He was the first to identify apoptosis in human joint chondrocytes, [9] [10] linking it to cartilage destruction in osteoarthritis and associating it with nitric oxide synthesis. [11] [12] Blanco's research focused on studying mitochondria's role in osteoarthritis ,leading the international study of mitochondrial genetics as biomarkers for the diagnosis, incidence, and prognosis of knee osteoarthritis. [13] [14] [15]
He has contributed significantly to the field of protein biomarkers in osteoarthritis, [16] recognized by OARSI in 2017.
Dr. Blanco is a co-founder of the PROCOAC cohort (Prospective Cohort of OsteoArthritis from Coruña) created in 2006. [17]
References
- ^ "ORCID – Francisco Javier Blanco García's profile". Retrieved 26 April 2024.
- ^ "University of A Coruña – Francisco Javier Blanco García's profile". Retrieved 23 April 2024.
- ^ "Francisco Blanco García – Servicio Gallego de Salud". portalcientifico.sergas.es. Retrieved 2024-05-02.
- ^ "Ilmo. Sr. D. Francisco Javier Blanco García – Real Academia Nacional de Medicina". www.ranm.es. Retrieved 2024-05-03.
- ^ "Académicos Correspondientes Actuales – Página 2 – Real Academia Nacional de Farmacia". ranf.com. Retrieved 2024-05-03.
- ^ Galegas, Páxinas. "Académicos colegiados en Galicia". www.ramycga.org (in Spanish). Retrieved 2024-05-03.
- ^ "Cátedra". Fundación San Rafael (in Spanish). Retrieved 2024-05-03.
- ^ "Francisco J Blanco's Bibliography – NCBI". www.ncbi.nlm.nih.gov. Retrieved 2024-05-02.
- ^ Blanco, F. J.; Guitian, R.; Vázquez-Martul, E.; de Toro, F. J.; Galdo, F. (1998). "Osteoarthritis chondrocytes die by apoptosis. A possible pathway for osteoarthritis pathology". Arthritis and Rheumatism. 41 (2): 284–289. doi: 10.1002/1529-0131(199802)41:2<284::AID-ART12>3.0.CO;2-T. ISSN 0004-3591. PMID 9485086.
- ^ Kim, H. A.; Blanco, F. J. (2007). "Cell death and apoptosis in osteoarthritic cartilage". Current Drug Targets. 8 (2): 333–345. doi: 10.2174/138945007779940025. ISSN 1873-5592. PMID 17305511.
- ^ Blanco, F. J.; Ochs, R. L.; Schwarz, H.; Lotz, M. (1995). "Chondrocyte apoptosis induced by nitric oxide". The American Journal of Pathology. 146 (1): 75–85. ISSN 0002-9440. PMC 1870754. PMID 7856740.
- ^ De Andrés, María C.; Maneiro, Emilia; Martín, Miguel A.; Arenas, Joaquín; Blanco, Francisco J. (2013-09-11). "Nitric oxide compounds have different effects profiles on human articular chondrocyte metabolism". Arthritis Research & Therapy. 15 (5): R115. doi: 10.1186/ar4295. ISSN 1478-6354. PMC 3978712. PMID 24025112.
- ^ Blanco, Francisco J.; López-Armada, Maria J.; Maneiro, Emilia (2004). "Mitochondrial dysfunction in osteoarthritis". Mitochondrion. 4 (5–6): 715–728. doi: 10.1016/j.mito.2004.07.022. ISSN 1567-7249. PMID 16120427.
- ^ Blanco, Francisco J.; Rego, Ignacio; Ruiz-Romero, Cristina (2011). "The role of mitochondria in osteoarthritis". Nature Reviews. Rheumatology. 7 (3): 161–169. doi: 10.1038/nrrheum.2010.213. ISSN 1759-4804. PMID 21200395.
- ^ Blanco, Francisco J.; Valdes, Ana M.; Rego-Pérez, Ignacio (2018). "Mitochondrial DNA variation and the pathogenesis of osteoarthritis phenotypes". Nature Reviews. Rheumatology. 14 (6): 327–340. doi: 10.1038/s41584-018-0001-0. ISSN 1759-4804. PMID 29670212.
- ^ Ruiz-Romero, C.; López-Armada, M. J.; Blanco, F. J. (2006). "Mitochondrial proteomic characterization of human normal articular chondrocytes". Osteoarthritis and Cartilage. 14 (6): 507–518. doi: 10.1016/j.joca.2005.12.004. ISSN 1063-4584. PMID 16520066.
- ^ Oreiro-Villar, Natividad; Raga, Ana C.; Rego-Pérez, Ignacio; Pértega, Sonia; Silva-Diaz, Maite; Freire, Mercedes; Fernández-López, Carlos; Blanco, Francisco J. (2022). "PROCOAC (PROspective COhort of A Coruña) description: Spanish prospective cohort to study osteoarthritis". Reumatologia Clinica. 18 (2): 100–104. doi: 10.1016/j.reumae.2020.08.004. hdl: 2183/31042. ISSN 2173-5743. PMID 35153032.
| Authority control databases: Academics |
|---|
Francisco Javier Blanco García, (1963, Honorary son of Cee, A Coruña) is a Spanish medical professional who has established a notable career in the field of rheumatology. [1] He holds the position of full professor in the Department of Physiotherapy, Medicine, and Biomedical Sciences at the Universidad de A Coruña. [2] Additionally, he serves as the Head of the Clinical and Translational Rheumatology Section at the A Coruña University Hospital and is the Coordinator of the Rheumatology-Health Research Group ( GIR) at INIBIC and CICA-UDC. [3] Francisco J Blanco is also a Corresponding Academic of the Royal National Academy of Medicine of Spain, [4] the Royal National Academy of Pharmacy of Spain, [5] and the Royal Academy of Medicine and Surgery of Galicia. [6] Recently, he was appointed Director of the Cathedra San Rafael Foundation-UDC. [7]
Research
Prof. Francisco Javier Blanco García's research is mainly focused on rheumatology, particularly in understanding osteoarthritis. [8] He was the first to identify apoptosis in human joint chondrocytes, [9] [10] linking it to cartilage destruction in osteoarthritis and associating it with nitric oxide synthesis. [11] [12] Blanco's research focused on studying mitochondria's role in osteoarthritis ,leading the international study of mitochondrial genetics as biomarkers for the diagnosis, incidence, and prognosis of knee osteoarthritis. [13] [14] [15]
He has contributed significantly to the field of protein biomarkers in osteoarthritis, [16] recognized by OARSI in 2017.
Dr. Blanco is a co-founder of the PROCOAC cohort (Prospective Cohort of OsteoArthritis from Coruña) created in 2006. [17]
References
- ^ "ORCID – Francisco Javier Blanco García's profile". Retrieved 26 April 2024.
- ^ "University of A Coruña – Francisco Javier Blanco García's profile". Retrieved 23 April 2024.
- ^ "Francisco Blanco García – Servicio Gallego de Salud". portalcientifico.sergas.es. Retrieved 2024-05-02.
- ^ "Ilmo. Sr. D. Francisco Javier Blanco García – Real Academia Nacional de Medicina". www.ranm.es. Retrieved 2024-05-03.
- ^ "Académicos Correspondientes Actuales – Página 2 – Real Academia Nacional de Farmacia". ranf.com. Retrieved 2024-05-03.
- ^ Galegas, Páxinas. "Académicos colegiados en Galicia". www.ramycga.org (in Spanish). Retrieved 2024-05-03.
- ^ "Cátedra". Fundación San Rafael (in Spanish). Retrieved 2024-05-03.
- ^ "Francisco J Blanco's Bibliography – NCBI". www.ncbi.nlm.nih.gov. Retrieved 2024-05-02.
- ^ Blanco, F. J.; Guitian, R.; Vázquez-Martul, E.; de Toro, F. J.; Galdo, F. (1998). "Osteoarthritis chondrocytes die by apoptosis. A possible pathway for osteoarthritis pathology". Arthritis and Rheumatism. 41 (2): 284–289. doi: 10.1002/1529-0131(199802)41:2<284::AID-ART12>3.0.CO;2-T. ISSN 0004-3591. PMID 9485086.
- ^ Kim, H. A.; Blanco, F. J. (2007). "Cell death and apoptosis in osteoarthritic cartilage". Current Drug Targets. 8 (2): 333–345. doi: 10.2174/138945007779940025. ISSN 1873-5592. PMID 17305511.
- ^ Blanco, F. J.; Ochs, R. L.; Schwarz, H.; Lotz, M. (1995). "Chondrocyte apoptosis induced by nitric oxide". The American Journal of Pathology. 146 (1): 75–85. ISSN 0002-9440. PMC 1870754. PMID 7856740.
- ^ De Andrés, María C.; Maneiro, Emilia; Martín, Miguel A.; Arenas, Joaquín; Blanco, Francisco J. (2013-09-11). "Nitric oxide compounds have different effects profiles on human articular chondrocyte metabolism". Arthritis Research & Therapy. 15 (5): R115. doi: 10.1186/ar4295. ISSN 1478-6354. PMC 3978712. PMID 24025112.
- ^ Blanco, Francisco J.; López-Armada, Maria J.; Maneiro, Emilia (2004). "Mitochondrial dysfunction in osteoarthritis". Mitochondrion. 4 (5–6): 715–728. doi: 10.1016/j.mito.2004.07.022. ISSN 1567-7249. PMID 16120427.
- ^ Blanco, Francisco J.; Rego, Ignacio; Ruiz-Romero, Cristina (2011). "The role of mitochondria in osteoarthritis". Nature Reviews. Rheumatology. 7 (3): 161–169. doi: 10.1038/nrrheum.2010.213. ISSN 1759-4804. PMID 21200395.
- ^ Blanco, Francisco J.; Valdes, Ana M.; Rego-Pérez, Ignacio (2018). "Mitochondrial DNA variation and the pathogenesis of osteoarthritis phenotypes". Nature Reviews. Rheumatology. 14 (6): 327–340. doi: 10.1038/s41584-018-0001-0. ISSN 1759-4804. PMID 29670212.
- ^ Ruiz-Romero, C.; López-Armada, M. J.; Blanco, F. J. (2006). "Mitochondrial proteomic characterization of human normal articular chondrocytes". Osteoarthritis and Cartilage. 14 (6): 507–518. doi: 10.1016/j.joca.2005.12.004. ISSN 1063-4584. PMID 16520066.
- ^ Oreiro-Villar, Natividad; Raga, Ana C.; Rego-Pérez, Ignacio; Pértega, Sonia; Silva-Diaz, Maite; Freire, Mercedes; Fernández-López, Carlos; Blanco, Francisco J. (2022). "PROCOAC (PROspective COhort of A Coruña) description: Spanish prospective cohort to study osteoarthritis". Reumatologia Clinica. 18 (2): 100–104. doi: 10.1016/j.reumae.2020.08.004. hdl: 2183/31042. ISSN 2173-5743. PMID 35153032.
| Authority control databases: Academics |
|---|